RHEUMATOLOGY 64 (6), 35003508
Li Y, Li Y, Yao Y et al (2023) Potential of cucurbitacin as an anticancer drug
9 Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2022
Stratified analyses by ejection fraction revealed that patients with borderline LVEF (5055%) exhibited more pronounced cardiovascular benefits, highlighting potential therapeutic overlap between HFpEF and HFmrEF
Open Book: Delivering transparent pharmacy benefits Transparency is how we operate on a daily basis, from independent clinical decisions to pass-through economics and real-time clarity at the point of care
It is such an important antioxidant that your body makes its own supply, using it for cancer protection , controlling DNA-damaging oxidative stress , supporting the body to detoxify efficiently, and maintaining healthy, rejuvenated cells throughout the body